mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.1 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.1 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
-0.084 |
0.1 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |